Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000514698 | SCV000171947 | benign | not provided | 2018-11-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23871722, 21441247, 27884173) |
Eurofins Ntd Llc |
RCV000128353 | SCV000331875 | benign | not specified | 2016-07-19 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514698 | SCV000610962 | benign | not provided | 2017-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000990807 | SCV000639941 | benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000514698 | SCV000844184 | benign | not provided | 2018-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000716736 | SCV000847579 | benign | History of neurodevelopmental disorder | 2016-01-08 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance;In silico models in agreement (benign);In silico models in agreement (deleterious) and/or completely conserved position in appropriate species;Subpopulation frequency in support of benign classification |
Mendelics | RCV000990807 | SCV001141849 | benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000514698 | SCV005277713 | benign | not provided | criteria provided, single submitter | not provided |